XTL Biopharmaceuticals Ltd.
XTLB
$1.26
-$0.07-5.26%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.07% | -9.07% | -7.43% | -17.14% | -22.71% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -62.34% | -62.34% | -34.75% | 78.79% | -7.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.38% | -10.38% | -8.72% | -14.99% | -22.70% |
|
|
|||||
| Total Current Assets | -10.38% | -10.38% | -8.72% | -14.99% | -22.70% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -8.90% | -8.90% | -7.57% | -13.28% | -20.64% |
|
|
|||||
| Total Accounts Payable | -99.38% | -99.38% | -0.61% | -32.37% | 11,950.00% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.16% | 27.16% | -0.61% | -32.37% | 28.88% |
|
|
|||||
| Total Current Liabilities | 27.16% | 27.16% | -0.61% | -32.37% | 28.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.16% | 27.16% | -0.61% | -32.37% | 28.88% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | -0.18% | -0.18% | -0.14% | -0.23% | -0.59% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -11.24% | -11.24% | -7.98% | -11.78% | -22.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.24% | -11.24% | -7.98% | -11.78% | -22.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.24% | -11.24% | -7.98% | -11.78% | -22.96% |
|
|
|||||